Table 3.
Two-Way ANOVA F-Test P-Values
|
Log2 Target/Rplp2 Mean ± SD (n)
|
||||||
---|---|---|---|---|---|---|---|
Target | Mcs1b Genotype | Exposure | G X E | Exposure | Susceptible | Mcs1b Resistant | P value* |
Gpbp1 | 0.0101 | 0.2090 | 0.6422 | Control | 0.586 ± 0.600 (34) | 0.044 ± 0.734 (29) | 0.0020 |
DMBA | 0.281 ± 1.309 (45) | −0.097 ± 1.246 (42) | 0.1716 | ||||
Mier3 | 0.0023 | 0.7911 | 0.6682 | Control | 0.115 ± 0.594 (34) | −0.522 ± 1.278 (34) | 0.0104 |
DMBA | 0.154 ± 1.557 (45) | −0.688 ± 1.943 (48) | 0.0240 | ||||
Map3k1 | 0.0002 | 0.0003 | 0.0588 | Control | −0.092 ± 0.818 (34) | −0.725 ± 0.767 (32) | 0.0019 |
DMBA | 0.105 ± 0.564 (47) | −0.104 ± 0.651 (45) | 0.1036 | ||||
Ankrd55 | 0.4694 | 0.2025 | 0.9019 | Control | −0.691 ± 0.678 (24) | −0.826 ± 1.108 (22) | 0.6180 |
DMBA | −0.377 ± 1.296 (17) | −0.567 ± 1.006 (22) | 0.6090 | ||||
Il6st | 0.0199 | 0.1744 | 0.8435 | Control | −0.066 ± 0.755 (36) | −0.418 ± 1.054 (33) | 0.1137 |
DMBA | 0.189 ± 1.006 (44) | −0.227 ± 1.181 (48) | 0.0734 | ||||
Il31ra | 0.2869 | 0.8674 | 0.9928 | Control | −0.331 ± 1.072 (24) | −0.559 ± 0.761 (23) | 0.4072 |
DMBA | −0.368 ± 0.942 (20) | −0.592 ± 1.159 (23) | 0.4949 | ||||
Ddx4 | 0.0555 | 0.5442 | 0.4045 | Control | −0.107 ± 0.983 (36) | −0.359 ± 0.911 (33) | 0.2748 |
DMBA | −0.055 ± 1.122 (18) | −0.690 ± 1.575 (17) | 0.1769 | ||||
Slc38a9 | 0.1008 | 0.3929 | 0.9730 | Control | −0.285 ± 0.600 (24) | −0.575 ± 0.681 (23) | 0.1284 |
DMBA | −0.144 ± 0.970 (20) | −0.422 ± 0.954 (23) | 0.3499 | ||||
Ppap2a | 0.3918 | 0.8314 | 0.5788 | Control | −0.385 ± 0.632 (24) | −0.447 ± 0.765 (23) | 0.7629 |
DMBA | −0.315 ± 1.357 (20) | −0.605 ± 1.029 (23) | 0.4315 |
Abbreviations: n, number of females; G, genotype; E, exposure; DMBA, 7,12-dimethylbenz[a]anthracene
Fisher’s PLSD test P values from comparing susceptible and Mcs1b resistant genotypes by exposure